Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer: Novel target to enhance radioiodine uptake in thyroid cancer.

Literature DB >> 23817292

Cancer: Novel target to enhance radioiodine uptake in thyroid cancer.

Gregory A Brent¹, Takahiko Kogai.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 23817292 DOI： 10.1038/nrendo.2013.132

Source DB: PubMed Journal: Nat Rev Endocrinol ISSN： 1759-5029 Impact factor: 43.330

× No keyword cloud information.

10 in total

1. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.

Authors: Debyani Chakravarty; Elmer Santos; Mabel Ryder; Jeffrey A Knauf; Xiao-Hui Liao; Brian L West; Gideon Bollag; Richard Kolesnick; Tin Htwe Thin; Neal Rosen; Pat Zanzonico; Steven M Larson; Samuel Refetoff; Ronald Ghossein; James A Fagin
Journal: J Clin Invest Date: 2011-11-21 Impact factor: 14.808

Review 2. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Authors: T Kogai; K Taki; G A Brent
Journal: Endocr Relat Cancer Date: 2006-09 Impact factor: 5.678

3. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.

Authors: Martin L Read; Greg D Lewy; Jim C W Fong; Neil Sharma; Robert I Seed; Vicki E Smith; Erica Gentilin; Adrian Warfield; Margaret C Eggo; Jeffrey A Knauf; Wendy E Leadbeater; John C Watkinson; Jayne A Franklyn; Kristien Boelaert; Christopher J McCabe
Journal: Cancer Res Date: 2011-08-15 Impact factor: 12.701

4. Pituitary tumor transforming gene binding factor: a new gene in breast cancer.

Authors: Rachel J Watkins; Martin L Read; Vicki E Smith; Neil Sharma; Gary M Reynolds; Laura Buckley; Craig Doig; Moray J Campbell; Greg Lewy; Margaret C Eggo; Laurence S Loubiere; Jayne A Franklyn; Kristien Boelaert; Christopher J McCabe
Journal: Cancer Res Date: 2010-04-20 Impact factor: 12.701

Review 5. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors: Takahiko Kogai; Gregory A Brent
Journal: Pharmacol Ther Date: 2012-06-29 Impact factor: 12.310

6. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.

Authors: Takahiko Kogai; Saima Sajid-Crockett; Lynell S Newmarch; Yan-Yun Liu; Gregory A Brent
Journal: J Endocrinol Date: 2008-09-01 Impact factor: 4.286

7. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.

Authors: Vicki E Smith; Martin L Read; Andrew S Turnell; Rachel J Watkins; John C Watkinson; Greg D Lewy; Jim C W Fong; Sally R James; Margaret C Eggo; Kristien Boelaert; Jayne A Franklyn; Christopher J McCabe
Journal: J Cell Sci Date: 2009-08-25 Impact factor: 5.285

8. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Authors: Alan L Ho; Ravinder K Grewal; Rebecca Leboeuf; Eric J Sherman; David G Pfister; Desiree Deandreis; Keith S Pentlow; Pat B Zanzonico; Sofia Haque; Somali Gavane; Ronald A Ghossein; Julio C Ricarte-Filho; José M Domínguez; Ronglai Shen; R Michael Tuttle; Steve M Larson; James A Fagin
Journal: N Engl J Med Date: 2013-02-14 Impact factor: 91.245

Review 9. The pituitary tumor transforming gene in thyroid cancer.

Authors: G D Lewy; N Sharma; R I Seed; V E Smith; K Boelaert; C J McCabe
Journal: J Endocrinol Invest Date: 2012-04-05 Impact factor: 4.256

10. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

Authors: V E Smith; N Sharma; R J Watkins; M L Read; G A Ryan; P P Kwan; A Martin; J C Watkinson; K Boelaert; J A Franklyn; C J McCabe
Journal: J Clin Endocrinol Metab Date: 2013-05-15 Impact factor: 5.958